HUE063567T2 - Alkoholszármazékok mint KV7 káliumcsatorna nyitók - Google Patents

Alkoholszármazékok mint KV7 káliumcsatorna nyitók

Info

Publication number
HUE063567T2
HUE063567T2 HUE18708346A HUE18708346A HUE063567T2 HU E063567 T2 HUE063567 T2 HU E063567T2 HU E18708346 A HUE18708346 A HU E18708346A HU E18708346 A HUE18708346 A HU E18708346A HU E063567 T2 HUE063567 T2 HU E063567T2
Authority
HU
Hungary
Prior art keywords
potassium channel
alcohol derivatives
channel openers
openers
derivatives
Prior art date
Application number
HUE18708346A
Other languages
English (en)
Inventor
Mario Rottländer
Anette Sams
Xiaofang Wang
Debasis Das
Jian Hong
Shu Chen
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of HUE063567T2 publication Critical patent/HUE063567T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/06Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/08Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/26Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being saturated and containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/04Systems containing only non-condensed rings with a four-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
HUE18708346A 2018-02-20 2018-02-20 Alkoholszármazékok mint KV7 káliumcsatorna nyitók HUE063567T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2018/054057 WO2019161877A1 (en) 2018-02-20 2018-02-20 Alcohol derivatives as kv7 potassium channel openers
EP18708346.4A EP3755684B1 (en) 2018-02-20 2018-02-20 Alcohol derivatives as kv7 potassium channel openers

Publications (1)

Publication Number Publication Date
HUE063567T2 true HUE063567T2 (hu) 2024-01-28

Family

ID=61557232

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE18708346A HUE063567T2 (hu) 2018-02-20 2018-02-20 Alkoholszármazékok mint KV7 káliumcsatorna nyitók

Country Status (11)

Country Link
EP (2) EP3755684B1 (hu)
JP (1) JP7121144B2 (hu)
CN (2) CN111727182B (hu)
ES (1) ES2951656T3 (hu)
HR (1) HRP20230808T1 (hu)
HU (1) HUE063567T2 (hu)
MA (1) MA51881B1 (hu)
MD (1) MD3755684T2 (hu)
PL (1) PL3755684T3 (hu)
RS (1) RS64479B1 (hu)
WO (1) WO2019161877A1 (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10590067B2 (en) 2018-02-20 2020-03-17 H. Lundbeck A/S Alcohol derivatives of carboxamides as Kv7 potassium channel openers
CR20220028A (es) * 2019-08-02 2022-03-02 H Lundbeck As DERIVADOS DE ALCOHOL COMO ABRIDORES DEL CANAL DE POTASIO Kv7
CN114206328A (zh) * 2019-08-02 2022-03-18 H.隆德贝克有限公司 用于在癫痫或癫痫发作中使用的作为Kv7钾通道开放剂的醇衍生物
AR119521A1 (es) 2019-08-02 2021-12-22 H Lundbeck As DERIVADOS DE ALCOHOL COMO ABRIDORES DEL CANAL DE POTASIO Kv7
CN115461327A (zh) 2020-04-29 2022-12-09 爱杜西亚药品有限公司 螺脲衍生物
JP2023531500A (ja) 2020-06-25 2023-07-24 イドーシア ファーマシューティカルズ リミテッド シクロブチル-ウレア誘導体
WO2024121779A1 (en) 2022-12-09 2024-06-13 Pfizer Inc. Papain-like protease (plpro) inhibitors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003534801A (ja) 2000-05-26 2003-11-25 ブリストル−マイヤーズ スクイブ カンパニー ヒトkcnq5カリウムチャンネル、並びにその方法および組成物
WO2001096540A2 (en) 2000-06-11 2001-12-20 Dupont Pharmaceuticals Company Hepatitis c protease exosite for inhibitor design
US7790770B2 (en) * 2005-11-23 2010-09-07 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
TWI453013B (zh) 2006-02-07 2014-09-21 Lundbeck & Co As H N-(2,4-二甲基-6-嗎啉-4-基-吡啶-3-基〉3,3-二甲基-丁醯胺之用途以及包含該化合物之醫藥品
JP2009530237A (ja) * 2006-03-15 2009-08-27 ノイロサーチ アクティーゼルスカブ キナゾリノン及びカリウムチャネル活性化剤としてのその使用
KR20100050502A (ko) 2007-08-01 2010-05-13 하. 룬드벡 아크티에셀스카브 도파민계가 붕괴되어 있는 장애 또는 병태의 증상을 감소 또는 치료하기 위한 kcnq 포타슘 채널 개방제의 용도
TW201024286A (en) * 2008-11-27 2010-07-01 Neurosearch As Novel compounds
CN104837811A (zh) * 2012-12-10 2015-08-12 H.隆德贝克有限公司 烟碱乙酰胆碱受体的新的正向別构调节剂
ES2885424T3 (es) * 2013-03-15 2021-12-13 Knopp Biosciences Llc Imidazo(4,5-B)piridin-2-il amidas como activadores del canal Kv7
US9481653B2 (en) * 2014-09-12 2016-11-01 Knopp Biosciences Llc Benzoimidazol-1,2-yl amides as Kv7 channel activators
JP2017095366A (ja) 2015-11-18 2017-06-01 持田製薬株式会社 新規ビアリールアミド誘導体
CN105663136A (zh) * 2016-01-15 2016-06-15 河北中医学院 法舒地尔作为制备选择性Kv7离子通道激活剂药物的应用

Also Published As

Publication number Publication date
RS64479B1 (sr) 2023-09-29
PL3755684T3 (pl) 2023-11-06
EP3755684A1 (en) 2020-12-30
ES2951656T3 (es) 2023-10-24
EP3755684B1 (en) 2023-07-12
CN116589375A (zh) 2023-08-15
EP4241843A3 (en) 2023-09-27
EP4241843A2 (en) 2023-09-13
EP3755684C0 (en) 2023-07-12
MA51881B1 (fr) 2023-08-31
JP7121144B2 (ja) 2022-08-17
MD3755684T2 (ro) 2023-11-30
CN111727182B (zh) 2023-05-26
BR112019021960A2 (pt) 2020-08-25
CN111727182A (zh) 2020-09-29
HRP20230808T1 (hr) 2023-11-10
JP2021519814A (ja) 2021-08-12
MA51881A (fr) 2020-12-30
WO2019161877A1 (en) 2019-08-29

Similar Documents

Publication Publication Date Title
HUE063567T2 (hu) Alkoholszármazékok mint KV7 káliumcsatorna nyitók
AU2015212265A1 (en) Anti-HER2 antibody-drug conjugate
EP3245227A4 (en) Multispecific immunomodulatory antigen-binding constructs
EP3130608A4 (en) (anti-her2 antibody)-drug conjugate
EP3748205A4 (en) SLIDING PARTS
EP3677802A4 (en) SLIDING PART
EP3590545A4 (en) COMPOSITION TO BE INJECTED INTO THE SKIN
EP3773721A4 (en) STABLE ANTI-CD79B IMMUNOCONJUGATE FORMULATIONS
IL268931B (en) New compounds for use as potassium channel openers
EP3653914A4 (en) SLIDING PARTS
EP3318245A4 (en) COSMETIC COMPOSITION BLOCKING UV
EP3294772A4 (en) BINDING CONSTRUCTS TO HER2 TARGETING ANTIGEN
EP3422924A4 (en) ENDOSCOPE WITH COMMON WORKING CHANNEL
EP4005420A4 (en) LOW TEMPERATURE SMOKE SET
KR101881983B1 (ko) 새로운 유형의 kcnq 칼륨 통로 작동제, 그의 제조 방법 및 그의 용도
EP3468523A4 (en) HYDRATING LIP BALM COMPOSITION
EP3801076A4 (en) CIGARETTE ROLLER
EP3476062A4 (en) TIME DELAY SETTING COMMUNICATION
IL282639A (en) Aryl sulfonyl pyrrole carboxamide derivatives as KV3 potassium station-activators
EP3375782A4 (en) SODIUM CHANNEL BLOCKER
EP3872375A4 (en) SLIDING ELEMENT
EP3825442A4 (en) SLIDING ELEMENT
EP3566796A4 (en) SLIDING NOZZLE
IL290193A (en) Alcohol derivatives as kv7 potassium channel openers
EP3765321A4 (en) SLIDING SUN VISOR